SELLAS Life Sciences Group, Inc. (SLS)

NASDAQ: SLS · Real-Time Price · USD

1.090

0.00 (0.00%)

At close: Apr 2, 2025, 4:00 PM

1.099

+0.009 (0.83%)

After-hours: Apr 2, 2025, 7:59 PM EDT

SLS Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-30.88	-37.34	-41.3	-20.7	-16.76	Upgrade
Asset Writedown & Restructuring Costs	-	-	10	5.7	-	Upgrade
Stock-Based Compensation	1.56	2.09	1.73	1.01	0.58	Upgrade
Other Operating Activities	0.56	0.49	0.13	-4.42	-0.11	Upgrade
Change in Accounts Payable	-2.14	2.3	1.21	-2.51	-0.84	Upgrade
Change in Unearned Revenue	-	-	-	-5.6	5.6	Upgrade
Change in Other Net Operating Assets	-4.51	1.04	4.43	0.5	1.11	Upgrade
Operating Cash Flow	-35.4	-31.41	-23.81	-26.02	-10.42	Upgrade
Sale (Purchase) of Intangibles	-	-5.5	-4.5	-	-	Upgrade
Investing Cash Flow	-	-5.5	-4.5	-	-	Upgrade
Issuance of Common Stock	46.82	22.35	24.08	12.07	38.44	Upgrade
Repurchase of Common Stock	-0.06	-0.03	-	-	-	Upgrade
Financing Cash Flow	46.76	22.32	24.08	12.07	38.44	Upgrade
Net Cash Flow	11.36	-14.6	-4.23	-13.95	28.03	Upgrade
Free Cash Flow	-35.4	-31.41	-23.81	-26.02	-10.42	Upgrade
Free Cash Flow Margin	-	-	-2380.90%	-342.38%	-548.26%	Upgrade
Free Cash Flow Per Share	-0.58	-1.13	-1.23	-1.68	-1.31	Upgrade
Levered Free Cash Flow	-24.25	-28.94	-11.87	-18.69	-3.6	Upgrade
Unlevered Free Cash Flow	-24.25	-28.94	-11.87	-18.69	-3.6	Upgrade
Change in Net Working Capital	6.12	1.87	-11.42	7.45	-6.44	Upgrade

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q